Lingjie Wu

1.5k citations
35 papers · 1.3k indexed · h-index 16
Topics
Nanoplatforms for cancer theranostics (11 papers)Nanoparticle-Based Drug Delivery (6 papers)Advanced biosensing and bioanalysis techniques (5 papers)
Partner nations
ChinaEgyptRwanda

In The Last Decade

Lingjie Wu

28 papers receiving 1.3k citations

Peers

Lingjie Wu
Comparison fields: 5 of 93
  • Biomedical Engineering 903
  • Materials Chemistry 509
  • Molecular Biology 398
  • Biomaterials 343
  • Pulmonary and Respiratory Medicine 202
Replace Cinzia Scialabba with:
Cinzia Scialabba Italy
Keyang Huang China
Wenqian Yu China
Xiaju Cheng China
Shengnan Yin China
Manman Liu China
Nicoletta Depalo Italy
Dong‐Bing Cheng China
Jaber Beik Iran
Lingjie Wu relative to Cinzia Scialabba Italy Cinzia Scialabba's profile →
Citations per field
00.5×1.5×2.2×
Cinzia Scialabba · 1×
Citations per year

Countries citing papers authored by Lingjie Wu

Since Specialization
Citations

This map shows the geographic impact of Lingjie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjie Wu more than expected).

Fields of papers citing papers by Lingjie Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingjie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjie Wu. The network helps show where Lingjie Wu may publish in the future.

Co-authorship network of co-authors of Lingjie Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingjie Wu. A scholar is included among the top collaborators of Lingjie Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjie Wu. Lingjie Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 0
5 0
6 0
7 1
8 2
9 1
10 13
11 0
12 16
13 4
14 51
15 77
16 24
17 61
18 47
19 38
20
Chemical and biological differentiation of three human breast cancer cell types using time-of-flight secondary ion mass spectrometry (TOF-SIMS)
2

About Lingjie Wu

Lingjie Wu is a scholar working on Transplantation, Biomaterials and Hepatology, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). The work is most often cited by research in Biomaterials (343 citations), Biomedical Engineering (903 citations) and Materials Chemistry (509 citations). Lingjie Wu has collaborated with scholars based in China, Egypt and Rwanda. Frequent co-authors include Xiaolong Liu, Ming Wu, Da Zhang, Jingfeng Liu, Yongyi Zeng, Huanghao Yang, Aixian Zheng, Qingtang Wang, Juan Li and Xiao Han. Their work appears in journals such as Analytical Chemistry, ACS Applied Materials & Interfaces and Nanoscale.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026